Pharmacosurveillance in Juvenile Idiopathic Arthritis

被引：6

作者：

Shiff, Natalie J. ^{[1
]}

Beukelman, Timothy ^{[2
]}

机构：

[1] Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Room 3250,East Wing,Hlth Sci Blvd,104 Clin Pl, Saskatoon, SK S7N 2Z4, Canada

[2] Univ Alabama Birmingham, Dept Pediat, Div Rheumatol, 1600 7th Ave South,CPPN G10, Birmingham, AL 35233 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2021年 / 47卷 / 04期

关键词：

JIA; Pediatric rheumatology; Pharmacosurveillance; Biologics; BIG-DATA; AMERICAN-COLLEGE; CHILDREN; RISK; PHARMACOVIGILANCE; ETANERCEPT; INFECTION; SAFETY; EXTRAPOLATION; INHIBITORS;

D O I：

10.1016/j.rdc.2021.07.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：643 / 653

页数：11

共 46 条

[1]

AAP News, AAP NEWS, V30

[2] Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future [J].

Alomar, Muaed ;

Tawfiq, Ali M. ;

Hassan, Nageeb ;

Palaian, Subish .

THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11

[3]

[Anonymous], 2020, Registries for evaluating patient outcomes: a user's guide

[4] The FDA's Sentinel Initiative-A Comprehensive Approach to Medical Product Surveillance [J].

Ball, R. ;

Robb, M. ;

Anderson, S. A. ;

Dal Pan, G. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (03) :265-268

[5] Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry [J].

Becker, Ingrid ;

Horneff, Gerd .

ARTHRITIS CARE & RESEARCH, 2017, 69 (04) :552-560

[6] Pharmacovigilance: An Overview [J].

Beninger, Paul .

CLINICAL THERAPEUTICS, 2018, 40 (12) :1991-2004

[7] Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors [J].

Beukelman, Timothy ;

Xie, Fenglong ;

Chen, Lang ;

Horton, Daniel B. ;

Lewis, James D. ;

Mamtani, Ronac ;

Mannion, Melissa M. ;

Saag, Kenneth G. ;

Curtis, Jeffrey R. .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (07) :1012-1016

[8] Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment [J].

Beukelman, Timothy ;

Xie, Fenglong ;

Chen, Lang ;

Baddley, John W. ;

Delzell, Elizabeth ;

Grijalva, Carlos G. ;

Lewis, James D. ;

Ouellet-Hellstrom, Rita ;

Patkar, Nivedita M. ;

Saag, Kenneth G. ;

Winthrop, Kevin L. ;

Curtis, Jeffrey R. .

ARTHRITIS AND RHEUMATISM, 2012, 64 (08) :2773-2780

[9] Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial [J].

Brunner, Hermine I. ;

Ruperto, Nicolino ;

Zuber, Zbigniew ;

Keane, Caroline ;

Harari, Olivier ;

Kenwright, Andrew ;

Lu, Peng ;

Cuttica, Ruben ;

Keltsev, Vladimir ;

Xavier, Ricardo M. ;

Calvo, Inmaculada ;

Nikishina, Irina ;

Rubio-Perez, Nadina ;

Alexeeva, Ekaterina ;

Chasnyk, Vyacheslav ;

Horneff, Gerd ;

Opoka-Winiarska, Violetta ;

Quartier, Pierre ;

Silva, Clovis A. ;

Silverman, Earl ;

Spindler, Alberto ;

Baildam, Eileen ;

Luz Gamir, M. ;

Martin, Alan ;

Rietschel, Christoph ;

Siri, Daniel ;

Smolewska, Elzbieta ;

Lovell, Daniel ;

Martini, Alberto ;

De Benedetti, Fabrizio .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :1110-1117

[10] Identifying the "Blip on the Radar Screen": Leveraging Big Data in Defining Drug Safety and Efficacy in Pediatric Practice [J].

Christensen, Michael L. ;

Davis, Robert L. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (10) :S86-S93

← 1 2 3 4 5 →